BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/6/2022 8:50:05 AM | Browse: 406 | Download: 830
 |
Received |
|
2021-12-05 21:05 |
|
Peer-Review Started |
|
2021-12-05 21:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-08 08:28 |
|
Revised |
|
2022-01-09 02:16 |
|
Second Decision |
|
2022-03-03 05:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-03-06 22:49 |
|
Articles in Press |
|
2022-03-06 22:49 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-30 08:01 |
|
Publish the Manuscript Online |
|
2022-04-06 08:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pathology |
| Manuscript Type |
Editorial |
| Article Title |
Hepatocellular adenoma: Where are we now?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xi Wang and Xuchen Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xuchen Zhang, MD, PhD, Associate Professor, Department of Pathology, Yale University School of Medicine, 310 Cedar Street, PO Box 208023, New Haven, CT 06520, United States. xuchen.zhang@yale.edu |
| Key Words |
Hepatocellular adenoma; Subtype; Pathology; Classification; Hepatocellular carcinoma |
| Core Tip |
Hepatocellular adenoma (HCA) has been well recognized as a benign liver neoplasm with risks of hemorrhage and malignant transformation. Studies revealed that different HCA subtypes with specific genetic mutation and pathologic findings are associated with different clinical features. Currently HCAs are classified into at least 5 major subtypes, involving 4 different pathways driving HCA pathogenesis: Hepatocyte nuclear factor 1A, interleukin-6/the Janus kinase/signal transducer and activator of transcription, β-catenin, and Sonic hedgehog pathway. |
| Publish Date |
2022-04-06 08:50 |
| Citation |
Wang X, Zhang X. Hepatocellular adenoma: Where are we now? World J Gastroenterol 2022; 28(14): 1384-1393 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i14/1384.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i14.1384 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
